Client Charter

We are devoted to strengthening emerging pharmaceutical markets. To this end, we commit to upholding essential principles in all of our dealings with clients. Our Client Charter is our promise to you that ...

Tag Archives: Health Insurance

Why all the negativity around national health insurance (NHI) in South Africa? There is so much bad news such as comments by the Solidarity Research Institute that NHI will collapse the healthcare system, the Free Market Foundation believes the NHI will be a gateway for corruption, and Alex van den Heever at Wits University thinks […]

Health insurance companies and governments use strong financial and administrative barriers to manage the utilization of new technologies. Cost-sharing (co-insurance or co-payments), prior authorization, clinical panel reviews, therapeutic reference pricing, and new technology appraisals are designed to manage the incremental uptake of new technologies. These technologies, for example, PCSK-9 inhibitors and enzyme replacement therapies, are […]

South Africa’s Cabinet of Ministers recently approved a White Paper on National Health Insurance aimed at moving the policy of universal health coverage further down the road. A National Health Insurance system would result in an integrated healthcare system founded on the principles of solidarity and redistribution of healthcare resources. The basic idea is that […]

The Spanish Ministry of Health recently rejected the use of QALYs in cost-effectiveness analyses. At issue is the subjective nature of the parameters used to develop the QALY. The Quality-Adjusted Life-Years (QALY) is a product of the change in utilities associated with a treatment multiplied by the time of treatment exposure. The QALYs gained combined […]

Marie-Paule Kieny, Assistant Director-General at the WHO published an interested comment on finding a comprehensive and fair solution to the price of medicines. The part that grabbed our attention was the reference to developing ” … a fair pricing model …”, see below. To that end, WHO is planning to convene governments, patient groups and […]

Carapinha & Consultants partnered with eyeforpharma to bring a webinar on creating value with accessed-based marketing. The webinar was structured around 3 core questions that eyeforpharma’s Paul Simms used to facilitate the discussion. Question 1 The first question, “In order for the industry to move forward, pharma has to prioritize” generated interesting results. 69% of respondents […]

We’ve joined eyeforpharma as their Strategic Partner to bring you a free webinar: “Remove barriers to entry by embracing an access-based approach to marketing” on Tuesday 26th May 2:30-3:30 pm SAST. Pharma companies in South Africa have products with compelling economic value propositions, however reimbursement constraints have limited the up-take and patient access to new therapies. But how do we […]

The second poster concerns Health Insurance Systems in Five Sub-Saharan African Countries. We found: – There is a lack of comprehensive information on medicines benefits in Sub-Saharan Africa – There are challenges with providing effective and efficient medicines benefits – Fraud is a serious issue which requires improved record management systems and provider/member education – […]

Access to care and medicines, burden of health care expenditures, and risk protection: Results from the World Health Survey Anita K. Wagner, Amy Johnson Gravesa, Sheila K. Reissa, Robert LeCatesa, Fang Zhanga and Dennis Ross-Degnan Objectives: We assessed the contribution of health insurance and a functioning public sector to access to care and medicines and […]